Provided by Tiger Fintech (Singapore) Pte. Ltd.

Zentalis Pharmaceuticals, LLC

1.40
+0.02501.82%
Volume:291.31K
Turnover:401.28K
Market Cap:100.18M
PE:-0.60
High:1.41
Open:1.35
Low:1.33
Close:1.37
Loading ...

Pleasing Signs As A Number Of Insiders Buy Zentalis Pharmaceuticals Stock

Simply Wall St.
·
29 Apr

Zentalis Pharmaceuticals Inc - Topline Data From Denali Part 2 Expected by Year End 2026

THOMSON REUTERS
·
28 Apr

Zentalis Pharmaceuticals Announces First Patient Dosed in DENALI Part 2 Clinical Trial of Azenosertib in Patients with Cyclin E1+ PROC

GlobeNewswire
·
28 Apr

Zentalis Pharmaceuticals Announces Poster Presentation at 2025 ASCO Annual Meeting

GlobeNewswire
·
24 Apr

BRIEF-Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Reuters
·
02 Apr

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
02 Apr

Promising Potential and Strategic Positioning Justify Buy Rating for Zentalis Pharmaceuticals

TIPRANKS
·
01 Apr

Analysts Conflicted on These Healthcare Names: Zentalis Pharmaceuticals (ZNTL) and Viking Therapeutics (VKTX)

TIPRANKS
·
31 Mar

Guggenheim Sticks to Their Buy Rating for Zentalis Pharmaceuticals (ZNTL)

TIPRANKS
·
30 Mar

Zentalis Pharmaceuticals Price Target Maintained With a $4.00/Share by Wedbush

Dow Jones
·
28 Mar

Stifel Nicolaus Sticks to Their Buy Rating for Zentalis Pharmaceuticals (ZNTL)

TIPRANKS
·
27 Mar

Oppenheimer Remains a Buy on Zentalis Pharmaceuticals (ZNTL)

TIPRANKS
·
27 Mar

Zentalis Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
27 Mar

BRIEF-Zentalis Pharmaceuticals Inc Files For Mixed Shelf Of Up To $250 Million - SEC Filing

Reuters
·
27 Mar

Zentalis Pharmaceuticals Inc Files for Mixed Shelf of up to $250 Mln - SEC Filing

THOMSON REUTERS
·
27 Mar

Zentalis Pharmaceuticals FY24 EPS ($2.33) Up From ($4.47) YoY)

Benzinga
·
27 Mar

Press Release: Zentalis Pharmaceuticals Reports Full Year 2024 Financial Results and Operational Updates

Dow Jones
·
27 Mar

Zentalis Pharmaceuticals Inc expected to post a loss of 71 cents a share - Earnings Preview

Reuters
·
21 Mar

Zentalis Pharmaceuticals Inc expected to post a loss of 71 cents a share - Earnings Preview

Reuters
·
17 Mar

Zentalis Pharmaceuticals Presents Updated Clinical Data at the Society of Gynecologic Oncology 2025 Annual Meeting on Women’s Cancer

GlobeNewswire
·
15 Mar